Cetuximab-mediated protection from hypoxia-induced cell death: implications for therapy sequence in colorectal cancer
- Sprache
-
Englisch
- Identifier
-
1221801546
Beteiligte Personen und Organisationen
Urban, Hans
Maurer, Gabriele Dorothea
Luger, Anna-Luisa
Lorenz, Nadja I.
Sauer, Benedikt
Stroh, Christopher
Trojan, Jörg
Mittelbronn, Michel
Steinbach, Joachim Peter
Harter, Patrick Nikolaus
Ronellenfitsch, Michael Wilfried
Maurer, Gabriele Dorothea
Luger, Anna-Luisa
Lorenz, Nadja I.
Sauer, Benedikt
Stroh, Christopher
Trojan, Jörg
Mittelbronn, Michel
Steinbach, Joachim Peter
Harter, Patrick Nikolaus
Ronellenfitsch, Michael Wilfried
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:55 MEZ
Beteiligte
- Urban, Hans
- Maurer, Gabriele Dorothea
- Luger, Anna-Luisa
- Lorenz, Nadja I.
- Sauer, Benedikt
- Stroh, Christopher
- Trojan, Jörg
- Mittelbronn, Michel
- Steinbach, Joachim Peter
- Harter, Patrick Nikolaus
- Ronellenfitsch, Michael Wilfried
Ähnliche Objekte (12)
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
Doxycycline impairs mitochondrial dunction and protects human glioma cells from hypoxia-induced cell death : implications of using tet-inducible systems
Activation of epidermal growth factor receptor sensitizes glioblastoma cells to hypoxia-induced cell death
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide
Second generation mtor inhibitors as a double-edged sword in malignant glioma treatment
Rescue of 2-Deoxyglucose side effects by ketogenic diet
Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
EGFR and mTOR as therapeutic targets in glioblastoma
Hypoxia enhances the antiglioma cytotoxicity of b10, a glycosylated derivative of betulinic acid
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastoma
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
Doxycycline impairs mitochondrial dunction and protects human glioma cells from hypoxia-induced cell death : implications of using tet-inducible systems
Activation of epidermal growth factor receptor sensitizes glioblastoma cells to hypoxia-induced cell death
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide
Second generation mtor inhibitors as a double-edged sword in malignant glioma treatment
Rescue of 2-Deoxyglucose side effects by ketogenic diet
Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
EGFR and mTOR as therapeutic targets in glioblastoma
Hypoxia enhances the antiglioma cytotoxicity of b10, a glycosylated derivative of betulinic acid
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastoma
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
Doxycycline impairs mitochondrial dunction and protects human glioma cells from hypoxia-induced cell death : implications of using tet-inducible systems
Activation of epidermal growth factor receptor sensitizes glioblastoma cells to hypoxia-induced cell death
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide
Second generation mtor inhibitors as a double-edged sword in malignant glioma treatment
Rescue of 2-Deoxyglucose side effects by ketogenic diet
Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
EGFR and mTOR as therapeutic targets in glioblastoma
Hypoxia enhances the antiglioma cytotoxicity of b10, a glycosylated derivative of betulinic acid
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastoma